JP2024535917A - 環状ｄｎａベクターの合成による生成 - Google Patents

環状ｄｎａベクターの合成による生成 Download PDF

Info

Publication number
JP2024535917A
JP2024535917A JP2024518929A JP2024518929A JP2024535917A JP 2024535917 A JP2024535917 A JP 2024535917A JP 2024518929 A JP2024518929 A JP 2024518929A JP 2024518929 A JP2024518929 A JP 2024518929A JP 2024535917 A JP2024535917 A JP 2024535917A
Authority
JP
Japan
Prior art keywords
therapeutic
dna
linear
sequence
dna vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518929A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535917A5 (enExample
Inventor
ジン ホ
アイリーン ハイアム
ホセ ローラ
ジョディ ケネディ
アンネ マグワイア
メイサム バクシュイシュ
エライザ ドーンブッシュ
Original Assignee
アルデブロン，エル．エル．シー．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルデブロン，エル．エル．シー． filed Critical アルデブロン，エル．エル．シー．
Publication of JP2024535917A publication Critical patent/JP2024535917A/ja
Publication of JP2024535917A5 publication Critical patent/JP2024535917A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024518929A 2021-09-27 2022-09-27 環状ｄｎａベクターの合成による生成 Pending JP2024535917A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163248801P 2021-09-27 2021-09-27
US63/248,801 2021-09-27
PCT/US2022/077108 WO2023049937A2 (en) 2021-09-27 2022-09-27 Synthetic production of circular dna vectors

Publications (2)

Publication Number Publication Date
JP2024535917A true JP2024535917A (ja) 2024-10-02
JP2024535917A5 JP2024535917A5 (enExample) 2025-10-06

Family

ID=85721330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518929A Pending JP2024535917A (ja) 2021-09-27 2022-09-27 環状ｄｎａベクターの合成による生成

Country Status (10)

Country Link
US (1) US20240409975A1 (enExample)
EP (1) EP4408994A4 (enExample)
JP (1) JP2024535917A (enExample)
KR (1) KR20240126447A (enExample)
CN (1) CN118679248A (enExample)
AU (1) AU2022349697A1 (enExample)
CA (1) CA3233230A1 (enExample)
IL (1) IL311778A (enExample)
MX (1) MX2024003870A (enExample)
WO (1) WO2023049937A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026515898A (ja) * 2023-04-28 2026-05-19 ユニバーシティ オブ メリーランド、バルティモア カウンティ インビトロでスーパーコイル状の環状ｄｎａを作製する方法
WO2025007021A2 (en) * 2023-06-30 2025-01-02 Novel Biotechnology Inc. Cell-free replication of a nucleic acid construct
WO2025175112A1 (en) * 2024-02-16 2025-08-21 University Of Maryland, Baltimore County Method for generating circular dna using heteroduplex thermostable ligation assembly of precursors produced by rolling circle amplification

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340264T1 (de) * 2003-06-10 2006-10-15 Mologen Ag Zirkuläres expressionskonstrukt für gentherapeutische anwendungen
WO2006063355A2 (en) * 2004-12-11 2006-06-15 Cytogenix , Inc. Cell free biosynthesis of high-quality nucleic acid and uses thereof
US8153598B2 (en) * 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
GB201321123D0 (en) * 2013-11-29 2014-01-15 Linea Ab Q Amplification of circular molecules
JP7058502B2 (ja) * 2014-04-11 2022-04-22 レッドボールト バイオサイエンシズ エルピー ゲノム適用および治療適用のための、核酸分子のクローン複製および増幅のためのシステムおよび方法
FR3032447B1 (fr) * 2015-02-10 2020-02-21 Universite Des Sciences Et Technologies De Lille-Lille 1 Procede de fabrication de vecteurs d'adn a partir de briques moleculaires contenant des sequences d'interet
JP7335224B2 (ja) * 2017-07-18 2023-08-29 ジェノヴィー エービー 全長ｔ細胞受容体オープンリーディングフレームの迅速な組立ておよび多様化のための二成分ベクターライブラリシステム
EP3987043A4 (en) * 2019-06-21 2023-07-19 Asklepios Biopharmaceutical, Inc. PRODUCTION OF VECTORS USING THE PHAGEN REPLICATION ORIGIN
WO2021055760A1 (en) * 2019-09-18 2021-03-25 Intergalactic Therapeutics, Inc. Synthetic dna vectors and methods of use

Also Published As

Publication number Publication date
US20240409975A1 (en) 2024-12-12
CA3233230A1 (en) 2023-03-30
WO2023049937A3 (en) 2023-08-10
MX2024003870A (es) 2024-09-11
IL311778A (en) 2024-05-01
CN118679248A (zh) 2024-09-20
AU2022349697A1 (en) 2024-05-16
KR20240126447A (ko) 2024-08-20
WO2023049937A2 (en) 2023-03-30
EP4408994A4 (en) 2025-04-09
EP4408994A2 (en) 2024-08-07

Similar Documents

Publication Publication Date Title
US9890391B2 (en) RNA vector with an open reading frame, an albumin 3′-UTR, and a histone stem loop
US20240409975A1 (en) Synthetic production of circular dna vectors
AU2019396520A1 (en) Anellosomes for delivering secreted therapeutic modalities
TW202411426A (zh) 經工程化的２類ｖ型ｃｒｉｓｐｒ系統
AU2019397058A1 (en) Anellosomes and methods of use
CA3186872A1 (en) Baculovirus expression systems
US20240376468A1 (en) CIRCULAR GUIDE RNAs FOR CRISPR/CAS EDITING SYSTEMS
WO2021252955A1 (en) Tandem anellovirus constructs
JP2023548838A (ja) ニワトリ貧血ウイルス（ｃａｖ）に基づくベクター
JP2022523806A (ja) 閉端ｄｎａ（ｃｅｄｎａ）および免疫調節化合物
US20250066809A1 (en) Production of gene therapy vector in engineered bacteria
WO2025081042A1 (en) Nickase-retron template-based precision editing system and methods of use
EP4731771A1 (en) Gene therapy vectors and methods of production and use thereof
KR20230044631A (ko) 자가 증폭이 가능하고 단백질을 합성하는 mRNA/DNA 하이브리드 시스템 및 이의 조성물
CA3211307A1 (en) Utrapure minivectors for gene therapy
JP2025536570A (ja) 核標的ｄｎａ送達及びその実践に使用するための組成物
WO2024249298A2 (en) Modified closed-ended dna (cedna) vectors, compositions, and uses thereof

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20240726

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250922

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250922

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20260212

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260213

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260803